Hepatopulmonary syndrome: The paradigm of liver-induced hypoxaemia

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 2, 1997, Pages 387-406

  Rodriguez Roisin, Robert ^a   Roca, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Gas exchange abnormalities; Liver failure; Liver transplantation; Nitric oxide; Pulmonary circulation; Ventilation perfusion relationships

Indexed keywords

ALMITRINE; CYCLOPHOSPHAMIDE; INDOMETACIN; METHYLENE BLUE; PROPRANOLOL; PROSTAGLANDIN; SOMATOSTATIN;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; GARLIC; HEART OUTPUT; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG GAS EXCHANGE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; VASODILATATION;

EID: 0030727859     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90046-4     Document Type: Article

References (64)

1. Agustí AGN, Roca J, Rodriguez-Roisin R et al (1989) Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. American Review of Respiratory Disease 139: 485-491.
2. Agustí AGN, Roca J, Bosch J & Rodriguez-Roisin R (1990) The lung in patients with cirrhosis. Journal of Hepatology 10: 251-257.
3. Andrivet P, Cadranel J, Housset B et al (1993) Mechanisms for impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency: effects of indomethacin. Chest 103: 500-507.
4. *Berthelot P, Walker JG, Sherlock S & Reid L (1966) Arterial changes in the lungs in cirrhosis of the liver-lung spider nevi. New England Journal of Medicine 274: 291-298.
5. Calabresi P & Abelmann WH (1957) Portocaval and porto-pulmonary anastomoses in Laennec's cirrhosis and in heart failure. Journal of Clinical Investigation 36: 1257-1265.
6. A/Q̇ matching in hypoxemic cirrhotic patients. Chest 96: 1064-1069.
7. Castro M & Krowka MJ (1996) Hepatopulmonary syndrome: a pulmonary vascular complication of liver disease. Clinics in Chest Medicine 17: 35-48.
8. Castro M, Krowka MJ, Beck KC et al (1994) Survival in liver transplant patients with pulmonary hypertension - correlation with pulmonary function (abstract). American Journal of Respiratory and Critical Care Medicine 149: A734.
9. *Chang S & Ohara N (1992) Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model Of the hepatopulmonary syndrome. American Review of Respiratory Disease 145: 798-805.
10. Crawford ABH, Regnis J, Laks L et al (1995) Pulmonary vascular dilatation and diffusion-dependent impairment of gas exchange in liver cirrhosis. European Respiratory Journal 8: 2015-2021.
11. *Cremona G, Higenbottam T, Mayoral V et al (1995) Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. European Respiratory Journal 8: 1883-1885.
12. Dantzker DR (1983) The influence of cardiovascular function on gas exchange. Clinics in Chest Medicine 4: 149-159.
13. Daoud FS, Reeves JT & Schaefer JW (1972) Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. Journal of Clinical Investigation 51: 1076-1080.
14. Edell ES, Cortese DE, Krowka MJ & Rehder K (1989) Severe hypoxemia and liver disease. American Review of Respiratory Disease 140: 1631-1635.
15. Eriksson LS (1991) Is intrapulmonary arteriovenous shunting and hypoxemia a contraindication for liver transplantation ? Hepatology 14: 575-576.
16. Eriksson LS, Söderman C, Wahren J et al (1988) Is hypoxemia in cirrhotic patients due to a functional 'hepato-pulmonal syndrome'? (abstract). Journal of Hepatology 1 (Supplement 1): S29.
17. Fahy JV, Kerr KM, Lake JR et al (1991) Pulmonary function before and after liver transplantation (abstract). American Review of Respiratory Disease 145: A303.
18. Flückiger M (1884) Vorkommen von trommelschägerformigen Fingerendphalangen ohne chronische Veränderungen and der Lungen oder am Herzen. Wiener Medizinische Wochenschrift 49: 1457-1458.
19. Fong Y, Marano MA, Moldawer LL et al (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. Journal of Clinical Investigation 85: 1896-1904.
20. Genovesi MG, Tierney DF, Taplin GV & Eisenberg H (1976) An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. American Review of Respiratory Disease 114: 59-65.
21. Georg J, Mellemgaard K, Tysgrup N & Winkler K (1960) Venoarterial shunts in cirrhosis of the liver. Lancet i: 852-854.
22. Groszmann RJ (1994) Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In Bosch J & Groszmann RJ (eds) Portal Hypertension. Pathophysiology and Treatment, pp 17-26. Oxford: Blackwell Scientific Publications.
23. Hedenstierna G, Söderman C, Eriksson LS & Wahren J (1991) Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. European Respiratory Journal 4: 711-717.
24. Hopkins WE, Waggoner AD & Barzilai B (1992) Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. American Journal of Cardiology 70: 516-519.
25. Hourani JM, Bellamy PE, Tashkin DP et al, (1991) Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. American Journal of Medicine 90: 693-700.
26. Jiménez W (1995) Endotelina, óxido nítrico y control de tono vascular: importancia fisiopatologica en la cirrosis hepática. Medicina Clinica (Barc) 104: 671-675.
27. Kennedy TC & Knudson RJ (1977) Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 72: 305-309.
28. G-methyl-L-arginine inhibits tumor necrosis factor induced hypotension: implications for the involvement of nitric oxide. Proceedings of the National Academy of Science USA 87: 3629-3632.
29. Kobzik L, Bredt DS, Lowenstein CJ et al (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. American Journal of Respiratory and Cell Molecular Biology 9: 371-377.
30. *Krowka MJ & Cortese DA (1989) Pulmonary aspects of liver disease and liver transplantation. Clinics in Chest Medicine 10: 593-616.
31. Krowka MJ & Cortese DA (1990) Hepatopulmonary syndrome. Chest 98: 1053-1054.
32. Krowka MJ & Cortese DA (1994) Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 105: 1528-1537.
33. *Krowka MJ, Dickson ER & Cortese DA (1993) Hepatopulmonary syndrome: clinical observations and lack of therapeutic response to somatostatin analogue. Chest 104: 515-521.
34. Krowka MJ, Dickson ER, Wiesner RH et al (1992) A prospective study of pulmonary function and gas exchange following liver transplantation. Chest 102: 1161-1166.
35. *Lange PA & Stoller JK (1996) The hepatopulmonary syndrome: effect of liver transplantation. Clinics in Chest Medicine 17: 115-124.
36. McAdams P, Erasmus J, Crokett R et al (1996) The hepatopulmonary syndrome: radiologic findings in 10 patients. American Journal of Radiology 166: 1379-1385.
37. Marks SA, Krowka MJ & Plevak DJ (1996) Prevalence of preperative hypoxemia in liver transplant (LT) patients, and relation to post transplant course. American Journal of Respiratory and Critical Care Medicine 153: A827.
38. Martinez-Pallí G, Barberà JA, Visa J et al (1996) Hepatopulmonary syndrome: prevalence and clinical markers (abstract). European Respiratory Journal 9: 179s.
39. Martini GA, Baltzer G & Arndt H (1972) Some aspects of circulatory disturbances in cirrhosis of the liver. Progress in Liver Disease 4: 231-250.
40. *Matsumoto A, Ogura K, Hirata Y et al (1995) Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Annals of Internal Medicine 123: 110-113.
41. Mélot C, Naeije R, Dechamps P et al (1989) Pulmonary and extrapulmonary factors to hypoxemia in liver cirrhosis. American Review of Respiratory Disease 139: 632-640.
42. Moncada S & Higgs A (1993) The L-arginine-nitric oxide pathway. New England Journal of Medicine 329: 2002-2012.
43. Naeije R, Hallemans R, Mois P & Mélot C (1981) Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest 80: 570-574.
44. Raffy O, Sleiman C, Vachiery F et al (1996) Refractory hypoxemia during liver cirrhosis. Hepatopulmonary syndrome or 'primary' pulmonary hypertension? American Journal of Respiratory and Critical Care Medicine 153: 1169-1171.
45. Riegler JL, Lang KA, Johnson SP & Westerman JH (1995) Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 109: 978-983.
46. Rodman T, Hurwitz JK, Pastor BH & Close HP (1959) Cyanosis, clubbing and arterial oxygen unsaturation associated with Laennec's cirrhosis. American Journal of Medical Science 238: 534-541.
47. Rodriguez-Roisin R (1995) Síndrome hepatopulmonar: un nuevo concepto. Un tratamiento nuevo? Medicina Clinica (Barc) 105: 269-274.
48. Rodriguez-Roisin R & Wagner PD (1989) Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination. European Respiratory Journal 3: 469-482.
49. Rodriguez-Roisin R & Krowka MJ (1994) Is arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach. European Respiration Journal 7: 839-842.
50. *Rodriguez-Roisin R, Agustí AGN & Roca J (1992) The hepatopulmonary syndrome: new name, old complexities. Thorax 47: 897-902.
51. *Rodriguez-Roisin R, Roca J, Agustí AGN et al (1987) Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. American Review of Respiratory Disease 135: 1085-1092.
52. Rolla G, Bucca C & Brussino L (1994) Methylene blue in the hepatopulmonary syndrome (letters to editor). New England Journal of Medicine 331: 1098.
53. Ruff F, Hughes JMB, Stanley NN et al (1971) Regional lung function in patients with hepatic cirrhosis. Journal of Clinical Investigation 50: 2403-2413.
54. Rydell R & Hoffbauer FW (1956) Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis. American Journal of Medicine 21: 450-460.
55. Sherlock S (1989) Disorders of the Liver and the Biliary System. 8th edn, pp 82-86. Oxford: Blackwell Scientific.
56. Sikuler E & Groszmann RJ (1986) Hemodynamic studies in long and short term portal hypertensive rats: the relation to systemic glucagon levels. Hepatology 6: 414-418.
57. Sogni P, Garnier P, Adano A et al (1995) Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with hepatic cirrhosis. Journal of Hepatology 23: 471-473.
58. Thiemerman C & Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. European Journal of Pharmacology 182: 591-595.
59. Thorens JB & Junod AF (1992) Hypoxaemia and liver cirrhosis: a new argument in favour of a 'diffusion-perfusion defect'. European Respiratory Journal 5: 754-756.
60. *Vallance P & Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337: 776-778.
61. Vanhoutte PM (1988) The endothelium-moderator of vascular smooth muscle tone. New England Journal of Medicine 319: 512-513.
62. Wagner PD & Rodriguez-Roisin R (1991) Clinical advances in pulmonary gas exchange. American Review of Respiratory Disease 143: 883-888.
63. West JB (1969) Ventilation-perfusion inequality and overall gas exchange in computer lung models of the lung. Respiratory Physiology 7: 88-110.
64. Williams A, Trewby P, Williams R & Reid L (1979) Structural alterations to the pulmonary circulation in fulminant hepatic failure. Thorax 34: 447-453.